BLU Stock

Shareholders should take the acquisition offer just announced for Canadian biopharm company Bellus H... Read More

Research Capital Corporation analyst André Uddin thinks Bellus Health (Bellus Stock Quote, Chart, N... Read More

Taking in some positive clinical results from Canadian drug company Bellus Health (Bellus Stock Quo... Read More

The global pharmaceutical and biotech industry has been getting a lot of attention over the past yea... Read More

Research Capital analyst André Uddin has revised his view on Bellus Health (Bellus Stock Quote, Cha... Read More

Research Capital Corporation analyst André Uddin has revised his view on Bellus Health (Bellus Stoc... Read More

Mackie Research analyst André Uddin reviewed the state of affairs for drug developer Bellus Health ... Read More

Negative top-line results from its Phase 2 clinical study are cause for a rating change on Bellus He... Read More

Mackie Research analyst André Uddin is holding steady with Bellus Health (Bellus Health Stock Quote... Read More

Recent shifts in the competitive landscape have Mackie Research Capital analyst André Uddin raising... Read More

After the fourth quarter and year end results from Bellus Health (Bellus Health Stock Quote, Chart T... Read More

Bellus Health (Bellus Health Stock Quote, Chart TSX:BLU) is all cashed-up to start a Phase II trial ... Read More

Clinical-stage drug company Bellus Health (Bellus Health Stock Quote, Chart: TSX:BLU) is developing ... Read More

Biopharmaceutical company Bellus Health Inc. (Bellus Health Stock Quote, Chart, News: TSX:BLU) is de... Read More

Canada’s Cashed up Tech Stocks, PART THREE. Companies Listed in the TSX, Technology, Cleantech... Read More